Today, Representatives Chrissy Houlahan (D-PA) and Stephanie Bice (R-OK), Co-Chairs and Co-Founders of the BIOTech Caucus, announced the Caucus’s first-ever slate of formally endorsed legislation. This milestone advances the Caucus’s mission to promote bipartisan solutions that maintain the United States’ global leadership on biotechnology.   

Caucus endorsement requires support from at least 75 percent of voting BIOTech Caucus members, a high bar designed to ensure strong bipartisan consensus. Both endorsed bills respond directly to recommendations from the National Security Commission on Emerging Biotechnology’s April 2025 report, which called for urgent federal action to maintain U.S. competitiveness and protect national security in the biotechnology sector. 

“The United States is in a global biotechnology race, and we can’t afford to fall behind,” said Co-Chairs Houlahan and Bice. “We’ve endorsed bills that deliver practical solutions for a competitive edge, strengthening federal coordination and investing in domestic biomanufacturing and workforce development. We’re proud that our first-ever endorsements reflect broad bipartisan support and look forward to building momentum as we secure America’s biotechnology future.” 

The endorsed legislation includes: 

• National Biotechnology Initiative Act (H.R. 2756) – Establishes a whole-of-government biotechnology strategy and interagency coordination across federal research and development, regulation, workforce development, and national security efforts. Co-Chair Stephanie Bice and Vice Chair Ro Khanna presented the bill for endorsement. 

• Biomanufacturing Excellence Act (H.R. 6089) – Creates a public-private National Biopharmaceutical Manufacturing Center of Excellence within the National Institute of Standards and Technology (NIST) to strengthen domestic manufacturing capacity, accelerate innovation, and train the next-generation workforce. Co-Chair Chrissy Houlahan and Rep. Jim Baird presented the bill for endorsement. 

Co-Chairs Houlahan and Bice also announced a major Caucus milestone: the Caucus has grown to 50 members—25 Republicans and 25 Democrats—reflecting strong bipartisan commitment to shaping America’s future in biotechnology.   

The Caucus welcomes continued engagement from stakeholders and encourages Members of Congress to propose additional bipartisan biotechnology legislation for future endorsement consideration. 


                                                                              ###